GHP Investment Advisors Inc. reduced its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 9.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,839 shares of the semiconductor company’s stock after selling 1,893 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Synopsys were worth $7,469,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Aaron Wealth Advisors LLC purchased a new position in shares of Synopsys during the first quarter worth about $596,000. Louisiana State Employees Retirement System purchased a new position in Synopsys during the 1st quarter worth approximately $8,842,000. Fairvoy Private Wealth LLC purchased a new position in Synopsys during the 1st quarter worth approximately $1,208,000. First American Bank increased its position in Synopsys by 1.9% during the first quarter. First American Bank now owns 2,398 shares of the semiconductor company’s stock worth $951,000 after buying an additional 44 shares during the period. Finally, Norway Savings Bank purchased a new stake in Synopsys in the first quarter valued at approximately $574,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Down 1.9%
Shares of NASDAQ SNPS opened at $455.02 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 52 week low of $376.18 and a 52 week high of $651.73. The firm has a 50-day moving average price of $483.35 and a 200 day moving average price of $462.20. The stock has a market capitalization of $87.13 billion, a price-to-earnings ratio of 105.33, a price-to-earnings-growth ratio of 2.73 and a beta of 1.22.
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.56% of the company’s stock.
Wall Street Analyst Weigh In
SNPS has been the topic of a number of research reports. Needham & Company LLC reissued a “buy” rating and set a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Morgan Stanley increased their price objective on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 28th. BNP Paribas Exane upped their price objective on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. Citigroup raised their price objective on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.
Read Our Latest Research Report on SNPS
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
